The Journal of Urology
Volume 178, Issue 6 , Pages 2247-2248 , December 2007

Predicting Bacillus Calmette-Guerin Immunotherapy Effectiveness

References 

  1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8
  2. Crispen R. History of BCG and its substrains. Prog Clin Biol Res. 1989;310:35
  3. Morales A, Eidinger D, Bruce AW. Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol. 1976;116:180
  4. deReijke TM, deBoer EC, Kurth KH, Schamhart DH. Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value. J Urol. 1996;155:477
  5. Kavoussi LR, Brown EJ, Ritchey JK, Ratliff TL. Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa (Requirement for the expression of an antitumor response). J Clin Invest. 1990;85:62
  6. deBoer EC, deJong WH, vanderMeijden AP, Steerenberg PA, Witjes F, Vegt PD, et al. Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer (A flow cytofluorometric analysis). Urol Res. 1991;19:45
  7. Hedges S, Agace W, Svensson M, Sjogren AC, Ceska M, Svanborg C. Uroepithelial cells are part of a mucosal cytokine network. Infect Immun. 1994;62:2315
  8. Haaff EO, Catalona WJ, Ratliff TL. Detection of interleukin 2 in the urine of patients with superficial bladder tumors after treatment with intravesical BCG. J Urol. 1986;136:970
  9. Nseyo UO, Whalen RK, Duncan MR, Berman B, Lundahl SL. Urinary cytokines following photodynamic therapy for bladder cancer (A preliminary report). Urology. 1990;36:167
  10. Brandau S, Bohle A. Activation of natural killer cells by bacillus Calmette-Guerin. Eur Urol. 2001;39:518
  11. Suttmann H, Jacobsen M, Reiss K, Jocham D, Bohle A, Brandau S. Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation. J Urol. 2004;172:1490
  12. Arnon TI, Achdout H, Levi O, Markel G, Saleh N, Katz G, et al. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol. 2005;6:515
  13. Doubrovina ES, Doubrovin MM, Vider E, Sisson RB, O’Reilly RJ, Dupont B, et al. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. J Immunol. 2003;171:6891

PII: S0022-5347(07)02262-8

doi: 10.1016/j.juro.2007.08.075

The Journal of Urology
Volume 178, Issue 6 , Pages 2247-2248 , December 2007